DOI QR코드

DOI QR Code

Imaging Patterns of Bacillus Calmette-Guérin-Related Granulomatous Prostatitis Based on Multiparametric MRI

  • Seungsoo Lee (Department of Radiology, Research Institute of Radiological Science, Yongin Severance Hospital, Yonsei University College of Medicine) ;
  • Young Taik Oh (Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Hye Min Kim (Department of Pathology, Yongin Severance Hospital, Yonsei University College of Medicine) ;
  • Dae Chul Jung (Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Hyesuk Hong (Department of Radiology, Research Institute and Hospital, National Cancer Center)
  • 투고 : 2020.11.18
  • 심사 : 2021.06.19
  • 발행 : 2022.01.01

초록

Objective: To categorize multiparametric MRI features of Bacillus Calmette-Guérin (BCG)-related granulomatous prostatitis (GP) and discover potential manifestations for its differential diagnosis from prostate cancer. Materials and Methods: The cases of BCG-related GP in 24 male (mean age ± standard deviation, 66.0 ± 9.4 years; range, 50-88 years) pathologically confirmed between January 2011 and April 2019 were retrospectively reviewed. All patients underwent intravesical BCG therapy followed by a MRI scan. Additional follow-up MRI scans, including diffusion-weighted imaging (DWI), were performed in 19 patients. The BCG-related GP cases were categorized into three: A, B, or C. The lesions with diffusion restriction and homogeneous enhancement were classified as type A. The lesions with diffusion restriction and a poorly enhancing component were classified as type B. A low signal intensity on high b-value DWI (b = 1000 s/mm2) was considered characteristic of type C. Two radiologists independently interpreted the MRI scans before making a consensus about the types. Results: The median lesion size was 22 mm with the interquartile range (IQR) of 18-26 mm as measured using the initial MRI scans. The lesion types were A, B, and C in 7, 15, and 2 patients, respectively. Cohen's kappa value for the inter-reader agreement for the interpretation of the lesion types was 0.837. On the last follow-up MRI scans of 19 patients, the size decreased (median, 5.8 mm; IQR, 3.4-8.5 mm), and the type changed from A or B to C in 11 patients. The lesions resolved in four patients. In five patients who underwent prostatectomy, caseous necrosis on histopathology matched with the non-enhancing components of type B lesions and the entire type C lesions. Conclusion: BCG-related GP demonstrated three imaging patterns on multiparametric MRI. Contrast-enhanced T1-weighted imaging and DWI may play a role in its differential diagnosis from prostate cancer.

키워드

참고문헌

  1. Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 2017;197:S142-S145 
  2. Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat EM, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 2017;71:447-461 
  3. Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, et al. Bladder cancer, version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017;15:1240-1267 
  4. Donin NM, Lenis AT, Holden S, Drakaki A, Pantuck A, Belldegrun A, et al. Immunotherapy for the treatment of urothelial carcinoma. J Urol 2017;197:14-22 
  5. Leibovici D, Zisman A, Chen-Levyi Z, Cypele H, Siegel YI, Faitelovich S, et al. Elevated prostate specific antigen serum levels after intravesical instillation of bacillus Calmette-Guerin. J Urol 2000;164:1546-1549 
  6. Alexander RB, Mann DL, Borkowski AA, Fernandez-Vina M, Klyushnenkova EN, Kodak J, et al. Granulomatous prostatitis linked to HLA-DRB1*1501. J Urol 2004;171:2326-2329 
  7. Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596-600 
  8. Stillwell TJ, Engen DE, Farrow GM. The clinical spectrum of granulomatous prostatitis: a report of 200 cases. J Urol 1987;138:320-323 
  9. Butel R, Ball R. The distribution of BCG prostatitis: a clue for pathogenetic processes? Prostate 2018;78:1134-1139 
  10. LaFontaine PD, Middleman BR, Graham SD Jr, Sanders WH. Incidence of granulomatous prostatitis and acid-fast bacilli after intravesical BCG therapy. Urology 1997;49:363-366 
  11. Garcia Solano J, Sanchez Sanchez C, Montalban Romero S, Perez-Guillermo M. Diagnostic dilemmas in the interpretation of fine-needle aspirates of granulomatous prostatitis. Diagn Cytopathol 1998;18:215-221 
  12. Uzoh CC, Uff JS, Okeke AA. Granulomatous prostatitis. BJU Int 2007;99:510-512 
  13. Beltrami P, Ruggera L, Cazzoletti L, Schiavone D, Zattoni F. Are prostate biopsies mandatory in patients with prostate-specific antigen increase during intravesical immunoor chemotherapy for superficial bladder cancer? Prostate 2008;68:1241-1247 
  14. Gottlieb J, Princenthal R, Cohen MI. Multi-parametric MRI findings of granulomatous prostatitis developing after intravesical bacillus calmette-guerin therapy. Abdom Radiol (NY) 2017;42:1963-1967 
  15. Kim CY, Lee SW, Choi SH, Son SH, Jung JH, Lee CH, et al. Granulomatous prostatitis after intravesical Bacillus Calmette-Guerin instillation therapy: a potential cause of incidental F-18 FDG uptake in the prostate gland on F-18 FDG PET/CT in patients with bladder cancer. Nucl Med Mol Imaging 2016;50:31-37 
  16. Bour L, Schull A, Delongchamps NB, Beuvon F, Muradyan N, Legmann P, et al. Multiparametric MRI features of granulomatous prostatitis and tubercular prostate abscess. Diagn Interv Imaging 2013;94:84-90 
  17. Ma W, Kang SK, Hricak H, Gerst SR, Zhang J. Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma. AJR Am J Roentgenol 2009;192:1494-1500 
  18. Suzuki T, Takeuchi M, Naiki T, Kawai N, Kohri K, Hara M, et al. MRI findings of granulomatous prostatitis developing after intravesical Bacillus Calmette-Guerin therapy. Clin Radiol 2013;68:595-599 
  19. Dianat SS, Matoso A, Carter BH, Macura KJ. Multiparametric MRI findings of granulomatous prostatitis after intravesical bacillus Calmette-Guerin therapy in a patient undergoing active surveillance. Clin Genitourin Cancer 2014;12:e215-e219 
  20. Diaz de Leon A, Costa DN, Francis F, Pedrosa I. Case 258: granulomatous prostatitis. Radiology 2018;289:267-271 
  21. Uysal A, Karaosmanog˘ lu AD, Karcaaltincaba M, Akata D, Akdogan B, Baydar DE, et al. Prostatitis, the great mimicker of prostate cancer: can we differentiate them quantitatively with multiparametric MRI? AJR Am J Roentgenol 2020;215:1104-1112 
  22. Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 2019;76:340-351